Liraglutide, semaglutide, and tirzepatide are all GLP-1 agonists resulting in significant weight loss in RCTs
While the GLP-1RA drugs have traditionally been used in type 2 diabetics, their ability to cause weight loss has captured the minds and imaginations of patients, providers, and drug manufacturers alike
A gradual dose reduction under medical supervision allows the body to adjust and supports a safer transition
Certain foods may stimulate natural GLP-1 release, including: High-protein foods such as eggs, fish, and legumes
The difference, which was statistically significant, amounted to a 52% increased risk of being diagnosed with stomach paralysis while on a GLP-1 medication
Sleeping on your left side and wearing loose clothing around the midsection reduces abdominal pressure and lowers the likelihood of nighttime acid reflux